Support and Resistance Levels
Past performance
About Emcure Pharmaceuticals Ltd Emcure Pharmaceuticals Limited is an Indian pharmaceutical company that has been a public entity since 2001. It specializes in developing, manufacturing, and marketing a wide range of pharmaceutical products globally, with a strong focus on research and development. The company operates in over 70 countries, maintaining a significant presence in India, Europe, and Canada, and targets both acute and chronic therapeutic areas, including gynecology, cardiovascular, and oncology. Emcure leverages a diverse product portfolio comprising orals, injectables, and biotherapeutics.
With 13 manufacturing facilities across India, Emcure has a robust track record in creating differentiated products, including chiral molecules and novel drug delivery systems. The company has expanded through strategic acquisitions and the establishment of subsidiaries in locations such as France, Chile, and the Philippines. Emcure's recent focus includes launching biosimilars and maintaining global patents for innovative treatments. In 2024, Emcure raised funds through an Initial Public Offering, issuing equity shares to support its growth initiatives.